Cargando…
Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines
BACKGROUND: Glycoengineering, in the biotechnology workhorse bacterium, Escherichia coli, is a rapidly evolving field, particularly for the production of glycoconjugate vaccine candidates (bioconjugation). Efficient production of glycoconjugates requires the coordinated expression within the bacteri...
Autores principales: | Kay, Emily J., Mauri, Marta, Willcocks, Sam J., Scott, Timothy A., Cuccui, Jon, Wren, Brendan W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026721/ https://www.ncbi.nlm.nih.gov/pubmed/35449016 http://dx.doi.org/10.1186/s12934-022-01792-7 |
Ejemplares similares
-
Recent advances in the production of recombinant glycoconjugate vaccines
por: Kay, Emily, et al.
Publicado: (2019) -
Recombinant expression of Streptococcus pneumoniae capsular polysaccharides in Escherichia coli
por: Kay, Emily J., et al.
Publicado: (2016) -
Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli
por: Samaras, Jasmin J., et al.
Publicado: (2021) -
Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines
por: Passmore, Ian J., et al.
Publicado: (2019) -
Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis
por: Cuccui, Jon, et al.
Publicado: (2013)